Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences. - Wikidata - awgldk - TriplyDB

Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences.

Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences.

http://www.wikidata.org/entity/Q38052857

about

Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease.Modern approach to the clinical management of non-alcoholic fatty liver disease Physical activity for the prevention and treatment of metabolic disorders.Effects of rhaponticum carthamoides versus glycyrrhiza glabra and punica granatum extracts on metabolic syndrome signs in rats.Non-alcoholic fatty liver disease may be associated with endothelial dysfunction.Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?A fatty acid analogue targeting mitochondria exerts a plasma triacylglycerol lowering effect in rats with impaired carnitine biosynthesis.

P2860

Q26776043-A28308A2-5F25-475F-82D8-AF6FB64958F5 Q28084150-661BCEC4-9916-4DB2-B52C-966974D03090 Q33583595-D44B35F8-2286-465B-A09F-B692E5A55D5F Q33886923-84D5A065-D641-4097-850F-C1BAFF967ECE Q38105296-192E5E39-F157-4C98-80C1-88D85383CB83 Q39213226-0A33C86A-E7C4-495B-9C3A-2BD0B8D44133 Q42574013-A8595665-AF01-4A24-A719-C9A0EF41C9A8 Q42736702-D415B477-CEB9-4FD4-BE8F-D204DCDCF23E Q55235061-59BD6439-16CA-4CF1-B5D1-A5A687C51CB5

P2860

Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences.

http://www.wikidata.org/entity/Q38052857

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Non-alcoholic fatty liver dise ...... pathophysiological evidences.

@en

type

label

Non-alcoholic fatty liver dise ...... pathophysiological evidences.

@en

prefLabel

Non-alcoholic fatty liver dise ...... pathophysiological evidences.

@en

P1433

Q38052857-1D163697-7B66-4AE1-8704-487B8F4964CF

P1476

Q38052857-49D977AA-1887-4B3F-86A9-90A94AA4204E

P2093

Q38052857-EA514878-C782-4E45-A5C2-4B723C30C835

Q38052857-EE034AC5-18C1-45A6-8175-6C35850F0B03

Q38052857-EE5807E1-761F-4072-A196-B357D69895E0

Q38052857-F938EF70-5065-4083-8520-7E61C0B117F0

P2860

Q38052857-04E7F056-DA64-4DBB-9D52-D7FE64FDA1B5

Q38052857-159210DC-9F60-428E-AFB2-4038475E3498

Q38052857-16F4AC4E-EF6F-416F-A33C-A5C9D501E5EB

Q38052857-242BE5BF-B439-4E9C-B830-59035C47557C

Q38052857-251452ED-0169-48F0-A496-098BC8AEA120

Q38052857-2B74B810-7DCD-4540-96A1-1A3DEA944089

Q38052857-2D4218D1-9EE0-4948-82E0-1A8B86D0B43E

Q38052857-2E0A495D-19EB-45D6-83ED-1959B82346E9

Q38052857-340DDADA-9B53-4ADE-82B0-3E66B607B619

Q38052857-341FF49A-DC96-48E9-8613-6D4A4B381B9C

P2888

Q38052857-69A80BC0-B0BC-451E-B9BC-52B75FD96ADC

P304

Q38052857-6433A48D-799B-4DD6-A709-7BD26DFABEEC

P31

Q38052857-D9927AFE-FE02-4206-8B9D-CE67A829BBC0

P356

Q38052857-2F906521-EB0A-4B4E-B76B-F55D27C0F199

P478

Q38052857-EF61B3F3-456D-4C5F-A89F-3FBB4507D2D0

P577

Q38052857-232A6D81-645D-4FA2-AB08-0F5108D80A2D

P5875

Q38052857-5F163617-47A1-4CDA-BA80-03BFF32D042B

P698

Q38052857-FEF9C415-AB5B-4E48-8763-3F74B916DC15

P921

Q38052857-2921BAFB-A8FB-4994-A740-28833E357E16

P356

S11739-012-0819-4

P1433

Internal and emergency medicine

P1476

Non-alcoholic fatty liver dise ...... pathophysiological evidences.

@en

P2093

Francesco Angelico

http://www.w3.org/2001/XMLSchema#string

Francesco Baratta

http://www.w3.org/2001/XMLSchema#string

Licia Polimeni

http://www.w3.org/2001/XMLSchema#string

Maria Del Ben

http://www.w3.org/2001/XMLSchema#string

P2860

Steatohepatitis: a tale of two "hits"?

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

Nonalcoholic fatty liver disease

Long-term follow-up of patients with NAFLD and elevated liver enzymes

HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.

Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?

Pathogenesis of steatohepatitis.

P2888

s11739-012-0819-4

P304

S291-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11739-012-0819-4

http://www.w3.org/2001/XMLSchema#string

P478

7 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232715267

http://www.w3.org/2001/XMLSchema#string

P698

23073870

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology